Liao Ted S, Yurgelun Matthew B, Chang Seong-Sil, Zhang Hui-Zhu, Murakami Koko, Blaine Theodore A, Parisien May V, Kim William, Winchester Robert J, Lee Francis Young-In
Center for Orthopaedic Research, Department of Orthopaedic Surgery, Columbia University, 622 W. 168th Street, BHN816, New York, NY 10032, USA.
J Orthop Res. 2005 Jan;23(1):203-9. doi: 10.1016/j.orthres.2004.06.018.
Giant cell tumor (GCT) of bone is a unique bone lesion that is characterized by an excessive number of multinucleated osteoclasts. GCT consists of neoplastic stromal cells, multinucleated osteoclasts and their precursors, thus serving as a naturally occurring human disease model for the study of osteoclastogenesis. It still remains unclear how stromal cells of GCT recruit osteoclast precursors. In the present study, we characterized the cellular components of GCT and confirmed the presence of CD14(+)-monocytes/CD68(+)-macrophages and CD34(+)-hematopoetic stem cells that express CXCR4, a specific receptor for SDF-1; SDF-1 gene expression and presence of SDF-1 protein were confirmed by real time RT-PCR, in situ hybridization, and immunohistochemistry in the GCT tissue and cultured cells. SDF-1 was present at 25-50 ng/ml in the conditioned media from the GCT cultures, which is in the range of physiological chemotactic concentration. Migration of osteoclast precursors was 2.5-fold higher in response to GCT conditioned media compared to the control media; and migration was inhibited by an average of 36% with anti-SDF-1 neutralizing antibody or competing recombinant SDF-1. These results suggest that SDF-1 is one of the significant chemoattractant factors involved in the recruitment of hematopoietic osteoclast precursor cells during tumor-induced osteoclastogenesis.
骨巨细胞瘤(GCT)是一种独特的骨病变,其特征是存在大量多核破骨细胞。GCT由肿瘤性基质细胞、多核破骨细胞及其前体细胞组成,因此是研究破骨细胞生成的天然人类疾病模型。目前仍不清楚GCT的基质细胞如何募集破骨细胞前体细胞。在本研究中,我们对GCT的细胞成分进行了表征,并证实了表达SDF-1特异性受体CXCR4的CD14(+)单核细胞/CD68(+)巨噬细胞和CD34(+)造血干细胞的存在;通过实时RT-PCR、原位杂交和免疫组织化学在GCT组织和培养细胞中证实了SDF-1基因表达和SDF-1蛋白的存在。GCT培养物的条件培养基中SDF-1的含量为25-50 ng/ml,处于生理趋化浓度范围内。与对照培养基相比,破骨细胞前体细胞对GCT条件培养基的迁移反应高出2.5倍;抗SDF-1中和抗体或竞争性重组SDF-1平均可抑制36%的迁移。这些结果表明,SDF-1是肿瘤诱导破骨细胞生成过程中参与募集造血破骨细胞前体细胞的重要趋化因子之一。